Back to Operative Surgery
Spine

Spine Tumour Decompression and Stabilization

Surgical technique guide for metastatic spinal cord compression and primary spine tumour surgery - FRCS exam preparation

Core Procedure
advanced
By OrthoVellum Medical Education Team

Reviewed by OrthoVellum Editorial Team

Editorial maintenance, source checking, and correction workflow • Published by OrthoVellum Medical Education Team

Editorial boardMethodologyReview policyReport a correction
High-yield overview

Posterior approach | SINS score for instability | Tokuhashi for prognosis | Separation surgery + SBRT | MDT decision-making

Metastatic Spinal Cord Compression (MSCC)

  • Neurological deficit (motor/sensory/sphincter) with imaging-confirmed cord compression
  • Progressive neurological deterioration despite radiotherapy
  • Mechanical instability (SINS ≥7)
  • Radioresistant tumour (renal, melanoma, sarcoma) requiring separation surgery + SBRT
  • Unknown primary requiring tissue diagnosis

Primary Spine Tumours

  • En bloc resection for isolated primary tumour with curative intent (Tokuhashi 12-15)
  • Decompression and stabilization for locally aggressive benign tumours

Mechanical Instability

  • SINS score 7-12: Potentially unstable - consider stabilization
  • SINS score 13-18: Unstable - requires stabilization
Mnemonic

SINS

Spinal Instability Neoplastic Score Components

Mnemonic

TOKUHASHI

Prognostic Scoring - Factors Assessed

Critical Danger Structures

Spinal Cord

Location: Within spinal canal, often compressed by tumour. Protection: Careful tumour debulking, avoid cord retraction, neuromonitoring (MEPs/SSEPs) essential.

Nerve Roots

Location: Exit through neural foramina. Protection: Identify before decompression, protect during laminectomy, trace if involved in tumour.

Segmental Vessels

Location: Along vertebral body at each level. At risk: Lateral decompression, corpectomy. May require ligation for exposure.

Thoracic Duct (T12-L2)

Location: Left side at thoracolumbar junction. At risk: Left-sided thoracolumbar approaches. Injury causes chylothorax.

Aorta/Vena Cava

Location: Anterior to vertebral bodies. At risk: Anterior approaches, screw malposition. Catastrophic if injured.

Dura/CSF

Location: Surrounds cord and nerve roots. At risk: Tumour invasion through dura, aggressive decompression. Repair if breached.

Surgical Anatomy

Tumour Location Patterns

Most metastatic spine tumours follow a predictable pattern:

  • Vertebral body: 70-80% (hematogenous spread via Batson's plexus)
  • Posterior elements: 20-30% (often extends from body)
  • Epidural space: Compression from vertebral body extension or soft tissue mass

Batson's Venous Plexus

Valveless venous network connecting pelvic and thoracic veins to vertebral venous plexus:

  • Explains predilection for spine metastases
  • Breast, prostate, lung, kidney, thyroid most common primaries ("BLT with a Kosher Pickle")

Surgical Corridors

Posterior approach provides:

  • Access to posterior elements and epidural space
  • Pedicle screw fixation points
  • Transpedicular access to vertebral body

Separation surgery corridor:

  • Create 2-3mm gap between tumour and thecal sac
  • Allows high-dose SBRT without cord myelopathy
  • Essential for radioresistant tumours (renal, melanoma)

Spinal Cord Blood Supply

  • Anterior spinal artery: Supplies anterior 2/3 of cord
  • Artery of Adamkiewicz: Major radicular artery, typically T9-L2 LEFT
  • Preserve during thoracolumbar tumour surgery

Positioning and Preparation

Patient Position: Prone on Jackson frame or Wilson frame. Arms at sides or 90° abduction. Head in neutral, eyes protected.

Neuromonitoring: Establish baseline MEPs and SSEPs before positioning. Alert threshold: >50% amplitude loss or 10% latency increase.

Cell Saver: Set up - metastatic tumour surgery can be bloody. Relative contraindication with haematological malignancies.

Fluoroscopy/Navigation: Confirm levels. Navigation useful for pathological bone, distorted anatomy.

Preoperative Planning Verification:

  • Confirm correct levels on preoperative imaging
  • Review SINS and Tokuhashi scores
  • Confirm MDT discussion and adjuvant RT plan
  • Check bloods: Hb, coagulation, group and save

Operative Technique

Step 1: Positioning and Level Verification

  • Prone on Jackson frame, arms tucked or abducted
  • Lateral fluoroscopy to confirm levels - COUNT FROM SACRUM
  • Mark incision (midline, 2-3 levels above and below tumour)
  • Establish neuromonitoring baseline

Clinical Pearl

EXAM KEY: Level counting errors are a "never event." Count from sacrum superiorly, and verify with lateral fluoro before incision. Mark levels with spinal needle if uncertain.

Step 2: Exposure and Pedicle Screw Placement

Exposure:

  • Midline incision over spinous processes
  • Subperiosteal dissection to transverse processes
  • Expose 2-3 levels above and below planned decompression

Pedicle Screw Placement:

  • Place screws BEFORE decompression (bone landmarks preserved)
  • Freehand technique or navigation-guided
  • Entry point: junction of transverse process and lateral border of superior articular facet
  • In osteopenic bone: consider fenestrated screws with cement augmentation

Clinical Pearl

EXAM KEY: Place screws BEFORE laminectomy - bone landmarks are easier to identify, and screws provide immediate stability if neurological deterioration during decompression.

Cement Augmentation

For osteopenic bone: Use fenestrated screws and inject PMMA under fluoroscopy. Avoid cement extravasation into canal or vessels. Allow polymerization before rod insertion.

Step 3: Laminectomy Over Compressed Segment

  • High-speed burr to thin lamina bilaterally
  • Complete laminectomy with Kerrison rongeurs
  • Preserve facet joints where possible (unless tumour-involved)
  • Identify and protect dura throughout

Clinical Pearl

EXAM KEY: Thin the lamina to "eggshell" thickness with burr before completing with Kerrison - safer for compromised dura and allows tactile feedback before dural contact.

Step 4: Epidural Tumour Debulking

Posterior Element Tumour:

  • Excise tumour-involved lamina en bloc if possible
  • Extend laterally into pedicle if involved

Epidural Compression (separation surgery):

  • Identify plane between tumour and dura
  • Debulk tumour circumferentially
  • Goal: create 2-3mm gap from thecal sac for SBRT
  • Do NOT attempt complete tumour resection (palliative surgery)

Separation Surgery Principle

Goal is to create space for radiotherapy, NOT curative resection. Attempting complete resection increases morbidity without survival benefit in metastatic disease. Leave residual tumour for SBRT.

Step 5: Transpedicular Vertebral Body Debulking

If anterior column involvement:

  • Curette through pedicle (transpedicular approach)
  • Remove tumour from vertebral body cavity
  • Preserve anterior and lateral cortical shell if intact

Clinical Pearl

EXAM KEY: Transpedicular debulking from posterior approach avoids morbidity of separate anterior approach. Useful for contained vertebral body lesions.

Step 6: Cement Augmentation of Vertebral Body

  • If vertebral body debulked or at risk of collapse
  • Inject PMMA under fluoroscopy through transpedicular cannula
  • Fill cavity with cement to restore mechanical strength
  • Watch for extravasation (epidural, foraminal, venous)

Step 7: Anterior Column Reconstruction (if needed)

For significant vertebral body destruction or corpectomy:

  • Expandable cage through posterolateral approach
  • OR anterior approach with strut graft/cage (separate procedure)
  • Provides load-sharing to protect posterior instrumentation

Step 8: Rod Placement and Final Construct

  • Pre-contour rods to match sagittal alignment
  • Insert rods and secure with set screws
  • Apply compression/distraction as needed
  • Add cross-links for rotational stability (especially 3+ level constructs)

Clinical Pearl

EXAM KEY: Cross-links are mandatory for rotational stability in tumour surgery where bone quality is compromised. Place at least one cross-link per construct.

Step 9: Final Inspection and Haemostasis

  • Inspect decompression site for residual compression
  • Check neuromonitoring - MEPs/SSEPs stable or improved
  • Meticulous haemostasis - tumour bed bleeds significantly
  • Consider topical hemostatic agents (Floseal, Surgicel)
  • Irrigate copiously

Step 10: Closure

  • Place subfascial drains (Jackson-Pratt) to prevent haematoma
  • Close deep fascia with heavy absorbable suture (0-Vicryl)
  • Subcutaneous and skin closure
  • Dry dressing

Step 11: Postoperative Care

Immediate:

  • ICU or HDU observation overnight
  • Neuro checks every 1-2 hours
  • DVT prophylaxis (LMWH when haemostasis secure)
  • Mobilize when medically stable

Adjuvant Therapy:

  • Radiotherapy planning within 2-4 weeks
  • SBRT for separation surgery cases
  • Oncology follow-up for systemic therapy

Step 12: Follow-up and Surveillance

  • Clinical review 2 weeks, 6 weeks, 3 months
  • MRI at 3 months to assess tumour response
  • Ongoing oncology/palliative care coordination
  • Repeat imaging if new symptoms

Complications

Complications: Recognition, Prevention, and Management

Clinical Decision Scenarios

Use these scenarios to practise clinical reasoning and management decisions

CLINICAL SCENARIOStandard

CLINICAL PROMPT

"A 62-year-old woman with known breast cancer presents with 48 hours of progressive lower limb weakness. She has 3/5 power in hip flexors, unable to walk. MRI shows T10 vertebral body collapse with epidural compression. How do you manage her?"

PRACTICAL APPROACH
This is metastatic spinal cord compression (MSCC), an oncological emergency. My immediate management includes high-dose steroids - dexamethasone 16mg IV bolus then 4mg QID to reduce cord oedema. I would perform a thorough neurological examination and document the Frankel/ASIA grade. For investigations, she needs urgent MRI whole spine to identify skip lesions, CT staging of chest/abdomen/pelvis, and baseline bloods including calcium. I calculate her SINS score - with vertebral body collapse, likely lytic lesion, and mechanical pain, this is likely to be 7 or higher indicating potential instability. Her Tokuhashi score with breast primary would likely be 9-11, suggesting palliative surgery is appropriate. Given she has progressive neurological deficit with ambulatory loss, the Patchell trial evidence (Lancet 2005) demonstrates that surgery plus radiotherapy is superior to radiotherapy alone for MSCC in patients with reasonable prognosis. Surgery should ideally be within 24-48 hours while she still has some motor function - recovery is much better when surgery precedes complete paralysis. I would plan posterior decompression T9-T11 laminectomy with pedicle screw fixation T7-L1, cement augmentation given metastatic bone, and possibly transpedicular vertebroplasty. This would be followed by adjuvant radiotherapy within 2-3 weeks.
CLINICAL SCENARIOStandard

CLINICAL PROMPT

"Explain the SINS score and how you would use it in clinical practice"

PRACTICAL APPROACH
The SPINAL INSTABILITY NEOPLASTIC SCORE (SINS) is a validated tool to assess mechanical instability in metastatic spine disease. It was developed by the Spine Oncology Study Group to help determine which patients need surgical stabilization. The score has six components, each scored 0-3 or 0-4. Location scores junctional spine (occipitocervical, cervicothoracic, thoracolumbar, lumbosacral) highest at 3 points because these areas experience highest mechanical stress. Mobile spine (C3-C6, L2-L4) scores 2, semi-rigid (T3-T10) scores 1, and rigid (S2-S5) scores 0. Pain is scored as mechanical (worse with movement) at 3 points, occasional/non-mechanical at 1, and pain-free at 0. The bone lesion type matters - lytic lesions score 2, mixed score 1, and blastic score 0 because lytic lesions weaken bone more. Spinal alignment with subluxation/translation scores 4, de novo deformity scores 2, and normal alignment scores 0. Vertebral body collapse greater than 50% scores 3, less than 50% scores 2, no collapse but more than 50% body involved scores 1, and none of the above scores 0. Finally, posterolateral element involvement (facets, pedicles) scores 3 if bilateral, 1 if unilateral, and 0 if not involved. The total score is 0-18. Scores 0-6 indicate stability - these patients can be managed with radiation alone. Scores 7-12 indicate POTENTIALLY unstable - these need individual assessment and often benefit from stabilization. Scores 13-18 indicate UNSTABLE - these require surgical stabilization.
CLINICAL SCENARIOStandard

CLINICAL PROMPT

"What is separation surgery and when would you use it?"

PRACTICAL APPROACH
Separation surgery is a surgical technique developed at Memorial Sloan Kettering that creates a circumferential margin between the tumour and the thecal sac, allowing high-dose stereotactic body radiotherapy (SBRT) to be delivered safely. The concept addresses the challenge of radioresistant tumours (renal cell carcinoma, melanoma, sarcoma) where conventional fractionated radiotherapy is ineffective, but the spinal cord tolerance limits the dose that can be delivered. In separation surgery, I perform a posterior approach with pedicle screw instrumentation, then debulk the epidural tumour to create a 2-3mm gap between the residual tumour and the dura. I am NOT attempting complete tumour resection - only creating enough separation for safe SBRT delivery. This margin allows doses of 18-24 Gray in a single fraction or hypofractionated regimens without exceeding spinal cord tolerance. The combination of separation surgery followed by SBRT has been shown to provide excellent local control rates of 85-95% even for radioresistant histologies. Indications include: radioresistant histology (renal, melanoma, sarcoma, thyroid), failure of prior conventional radiotherapy, high-grade epidural compression with good prognosis, and when local control is important for quality of life. The surgery is palliative - I am not attempting cure, but optimizing the setup for effective radiotherapy.

Spine Tumour Decompression and Stabilization - Exam Summary

Clinical summary

Evidence Base

Direct decompressive surgical resection in spinal cord compression caused by metastatic cancer: a randomised trial

Level I
Patchell RA, Tibbs PA, Regine WF, et al. • Lancet
Clinical Implication: The landmark trial establishing surgery plus postoperative radiotherapy as superior to radiotherapy alone for MSCC. Note the strict entry criteria: a single area of compression, not paraplegic for more than 48 hours, and radiosensitive histologies (myeloma, lymphoma, germ cell) excluded. These criteria, not just the headline result, are the examinable point.
Verify on PubMed (PMID 16112300)

A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group

Guideline
Fisher CG, DiPaola CP, Ryken TC, et al. • Spine (Phila Pa 1976)
Clinical Implication: The internationally adopted common language for neoplastic spinal instability. SINS assesses mechanical stability only and is complementary to neurological status (ESCC grade) and prognosis (Tokuhashi) in the decision framework.
Verify on PubMed (PMID 20562730)

Spinal instability neoplastic score: an analysis of reliability and validity from the Spine Oncology Study Group

Level II
Fourney DR, Frangou EM, Ryken TC, et al. • J Clin Oncol
Clinical Implication: Confirms SINS as a reliable, reproducible and valid tool, supporting its routine use across surgeons and institutions worldwide. The high sensitivity makes it an effective screening trigger for surgical referral.
Verify on PubMed (PMID 21709187)

A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis

Level III
Tokuhashi Y, Matsuzaki H, Oda H, et al. • Spine (Phila Pa 1976)
Clinical Implication: A widely used prognostic tool guiding the goal of surgery (palliative versus excisional). It should inform, not replace, MDT judgement, and modern systemic and targeted therapies can outperform the historical survival estimates for some histologies.
Verify on PubMed (PMID 16205345)

Local disease control for spinal metastases following 'separation surgery' and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients

Level III
Laufer I, Iorgulescu JB, Chapman T, et al. • J Neurosurg Spine
Clinical Implication: Underpins the hybrid 'separation surgery plus SBRT' paradigm: limited surgery to create a margin around the cord, then high-dose conformal radiosurgery for durable local control even in conventionally radioresistant histologies (renal, melanoma, sarcoma, thyroid).
Verify on PubMed (PMID 23339593)

Guidelines, Registries & Global Practice

Major Society and Guideline Positions

SourceKey recommendation
NICE NG (formerly CG75), UKTreat suspected MSCC as an emergency; definitive treatment (surgery or radiotherapy) before further neurological deterioration and ideally within 24 hours of diagnosis in a patient with deficit or instability
NCCN / NACTRAC consensus, North AmericaMDT-led pathway; surgery for instability, high-grade epidural compression, or radioresistant tumour, followed by SBRT
Spine Oncology Study Group (international)Use the NOMS framework (Neurologic, Oncologic, Mechanical, Systemic) and SINS to standardise decision-making globally
EANO / ESMO (Europe)Early decompressive surgery plus RT for good-prognosis patients with cord compression, dexamethasone for symptomatic oedema

The NOMS Decision Framework (Memorial Sloan Kettering)

A globally applicable mental model that integrates the scores above:

  • N — Neurologic: degree of epidural cord compression (Bilsky ESCC grade) and myelopathy
  • O — Oncologic: tumour radiosensitivity and expected response to systemic/radiotherapy
  • M — Mechanical: stability assessed by SINS (instability needs stabilisation regardless of radiosensitivity)
  • S — Systemic: disease burden, comorbidity and ability to tolerate surgery (informed by Tokuhashi/Tomita)

Registry and Outcome Context

  • Modern targeted and immunotherapy agents (e.g. for renal cell and melanoma) have lengthened survival, so historical prognostic scores increasingly underestimate survival for some histologies — re-assess prognosis at the MDT rather than relying on the score alone.
  • Minimally invasive and percutaneous cement augmentation/stabilisation techniques are increasingly used for poor-surgical-candidate patients to control mechanical pain without open decompression.

References

  1. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366(9486):643-648.

  2. Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine. 2010;35(22):E1221-E1229.

  3. Tokuhashi Y, Matsuzaki H, Oda H, et al. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine. 2005;30(19):2186-2191.

  4. Laufer I, Iorgulescu JB, Chapman T, et al. Local disease control for spinal metastases following "separation surgery" and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients. J Neurosurg Spine. 2013;18(3):207-214.

  5. Bilsky MH, Laufer I, Fourney DR, et al. Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine. 2010;13(3):324-328.

  6. National Institute for Health and Care Excellence (NICE). Metastatic spinal cord compression in adults: risk assessment, diagnosis and management. CG75. 2008 (updated 2014).

  7. Rades D, Fehlauer F, Schulte R, et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol. 2006;24(21):3388-3393.

  8. Yamada Y, Bilsky MH, Lovelock DM, et al. High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys. 2008;71(2):484-490.

  9. Klimo P Jr, Thompson CJ, Kestle JR, Schmidt MH. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro Oncol. 2005;7(1):64-76.

  10. Fourney DR, Frangou EM, Ryken TC, et al. Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol. 2011;29(22):3072-3077.